D3 bio is a global biotechnology company focusing on the development of cancer and immune precision therapy drugs
Employees: 11-50
Total raised: $240M
Founded date: 2020
Investors 1
| Date | Name | Website |
| 09.02.2022 | Matrix Par... | matrixpart... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 08.04.2024 | - | $40M | - |
| 18.11.2020 | Series A | $200M | - |
Mentions in press and media 7
| Date | Title | Description | Source |
| 10.04.2024 | Agri-focused Antibiotic Alternative Startup Peptobiotics Rai... | Peptobiotics, a Singapore startup, secures $6.2 million in series A funding to market its antibiotic... | parsers.vc... |
| 09.04.2024 | Deals in brief: Peptobiotics raises USD 6.2 million, Meaning... | NewsDeals in brief: Smartpay and WYZauto secure funding, SGX-listed APS to acquire Mobii Network, se... | kr-asia.co... |
| 08.04.2024 | D3 Bio Receives $40M Investment from Medicxi | D3 Bio, a JiangSu and Shanghai, China-based biotechnology company, received $40M in Investment from ... | finsmes.co... |
| 08.04.2024 | D3 Bio Completes Series A+ Round to Advance Innovative Oncol... | SHANGHAI, April 8, 2024 /PRNewswire/ -- D3 Bio, an emerging global biotechnology company that focuse... | en.prnasia... |
| 14.03.2024 | D3 Bio Appoints Dr. Antoine Yver as Independent Board Member | SHANGHAI, March 14, 2024 /PRNewswire/ -- D3 Bio, an emerging global biotechnology company that focus... | en.prnasia... |
| 18.11.2020 | D3 Bio Raises US$200M in Series A Financing | George Chen, MD D3 Bio, a Shangai, China-based global biotechnology company focused on developing an... | finsmes.co... |
| - | D3 Bio | “D3 Bio, Inc” | fastfounde... |